These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23940286)

  • 1. Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer.
    Ajona D; Pajares MJ; Corrales L; Perez-Gracia JL; Agorreta J; Lozano MD; Torre W; Massion PP; de-Torres JP; Jantus-Lewintre E; Camps C; Zulueta JJ; Montuenga LM; Pio R
    J Natl Cancer Inst; 2013 Sep; 105(18):1385-93. PubMed ID: 23940286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of the complement activation product C4d in bronchial fluids for the diagnosis of lung cancer.
    Ajona D; Razquin C; Pastor MD; Pajares MJ; Garcia J; Cardenal F; Fleischhacker M; Lozano MD; Zulueta JJ; Schmidt B; Nadal E; Paz-Ares L; Montuenga LM; Pio R
    PLoS One; 2015; 10(3):e0119878. PubMed ID: 25799154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma.
    Ajona D; Pajares MJ; Chiara MD; Rodrigo JP; Jantus-Lewintre E; Camps C; Suarez C; Bagán JV; Montuenga LM; Pio R
    Oral Dis; 2015 Oct; 21(7):899-904. PubMed ID: 26258989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free Airway C4d after Lung Transplantation - A Quantitative Analysis of Bronchoalveolar Lavage Fluid.
    Heigl T; Saez-Gimenez B; Van Herck A; Kaes J; Sacreas A; Beeckmans H; Ambrocio GPL; Kwakkel-Van Erp H; Ordies S; Vanstapel A; Verleden SE; Neyrinck AP; Ceulemans LJ; Van Raemdonck DE; Verbeken E; Verleden GM; Vos R; Vanaudenaerde B
    Transpl Immunol; 2021 Feb; 64():101352. PubMed ID: 33217540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement Factor C4d Is a Common Denominator in Thrombotic Microangiopathy.
    Chua JS; Baelde HJ; Zandbergen M; Wilhelmus S; van Es LA; de Fijter JW; Bruijn JA; Bajema IM; Cohen D
    J Am Soc Nephrol; 2015 Sep; 26(9):2239-47. PubMed ID: 25573909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of C4d as a diagnostic tool to classify membranoproliferative glomerulonephritis.
    Gupta N; Wakefield DN; Clapp WL; Garin EH
    Nefrologia; 2017; 37(1):78-86. PubMed ID: 27595516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-human leukocyte antigen antibodies, vascular C4d deposition and increased soluble c4d in broncho-alveolar lavage of lung allografts.
    Girnita AL; Lee TM; McCurry KR; Baldwin WM; Yousem SA; Detrick B; Pilewski J; Toyoda Y; Jelinek L; Lomago J; Zaldonis D; Spichty KJ; Zeevi A
    Transplantation; 2008 Jul; 86(2):342-7. PubMed ID: 18645500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.
    Kikić Ž; Kainz A; Kozakowski N; Oberbauer R; Regele H; Bond G; Böhmig GA
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1435-43. PubMed ID: 26071493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation in astrocytomas: deposition of C4d and patient outcome.
    Mäkelä K; Helén P; Haapasalo H; Paavonen T
    BMC Cancer; 2012 Dec; 12():565. PubMed ID: 23199209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis?
    Lood C; Eriksson S; Gullstrand B; Jönsen A; Sturfelt G; Truedsson L; Bengtsson AA
    Lupus; 2012 Nov; 21(13):1423-32. PubMed ID: 22878256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
    Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
    Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of platelet C4d with all-cause mortality and ischemic stroke in patients with systemic lupus erythematosus.
    Kao AH; McBurney CA; Sattar A; Lertratanakul A; Wilson NL; Rutman S; Paul B; Navratil JS; Scioscia A; Ahearn JM; Manzi S
    Transl Stroke Res; 2014 Aug; 5(4):510-8. PubMed ID: 24323718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of new technique that measures C4d for assessment of activation of classical complement pathway.
    Davies ET; Nasaruddin BA; Alhaq A; Senaldi G; Vergani D
    J Clin Pathol; 1988 Feb; 41(2):143-7. PubMed ID: 3350977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C3d and C4d deposition early after lung transplantation.
    Westall GP; Snell GI; McLean C; Kotsimbos T; Williams T; Magro C
    J Heart Lung Transplant; 2008 Jul; 27(7):722-8. PubMed ID: 18582800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipients.
    Vallhonrat H; Williams WW; Cosimi AB; Tolkoff-Rubin N; Ginns LC; Wain JC; Preffer F; Olszak I; Wee S; Delmonico FL; Pascual M
    Transplantation; 1999 Jan; 67(2):253-8. PubMed ID: 10075589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of complement activation products in Chinese patients with systemic lupus erythematosus.
    Li J; An L; Zhang Z
    Clin Exp Rheumatol; 2014; 32(1):48-53. PubMed ID: 23981509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies.
    Behr TM; Feucht HE; Richter K; Reiter C; Spes CH; Pongratz D; Uberfuhr P; Meiser B; Theisen K; Angermann CE
    J Heart Lung Transplant; 1999 Sep; 18(9):904-12. PubMed ID: 10528753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus.
    Svenungsson E; Gustafsson JT; Grosso G; Rossides M; Gunnarsson I; Jensen-Urstad K; Larsson A; Ekdahl KN; Nilsson B; Bengtsson AA; Lood C
    Rheumatology (Oxford); 2020 Nov; 59(11):3264-3274. PubMed ID: 32259250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classical complement activation induced by pregnancy: implications for management of connective tissue diseases.
    Hopkinson ND; Powell RJ
    J Clin Pathol; 1992 Jan; 45(1):66-7. PubMed ID: 1740520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular c4d staining can be an indicator of disease activity in lupus nephritis.
    Sahin OZ; Gurses S; Taslı F; Yavas H; Ersoy R; Uzum A; Cirit M
    Ren Fail; 2013; 35(2):222-5. PubMed ID: 23176021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.